Looking behind the Solubilization Curtain: Microdialysis Provides Near-Real-Time Noncolloidal Drug Concentrations during In Vitro Lipolysis

Lipid-based formulations can enhance the oral absorption of poorly water-soluble drugs. Their performance is typically evaluated by in vitro lipolysis. For this, samples are usually prepared by centrifugation, and formulation performance is evaluated based on the concentration in the aqueous phase. However, several studies have questioned the predictiveness of the in vitro lipolysis method. A reason for the in vitro-in vivo mismatch may be that centrifugation cannot separate truly dissolved drug molecules from molecules associated with colloidal assemblies such as mixed micelles. The present study tested microdialysis as an alternative sampling technique for in vitro lipolysis by which truly dissolved drug molecules (i.e., the free fraction) can be separated from colloid-associated drug molecules. Thereby, a better mechanistic understanding of the formulation performance will possibly be achieved. Indomethacin and a medium-chain type IIIB lipid-based formulation were used as model drug and model formulation, respectively. Microdialysis sampling was found compatible with lipolysis medium with bile salts, phospholipids, and pancreatic enzymes. In a proof-of-concept study, microdialysis provided near-real-time concentrations of free indomethacin during the in vitro lipolysis process and revealed supersaturation of indomethacin. However, indomethacin supersaturation was also observed under nonlipolytic conditions. Based on microdialysis data, digestion would not influence the formulation performance. In contrast, conventional samples showed that lipolysis significantly decreased the solubilization capacity of the formulation. Other examples have been described in the literature where oral absorption from lipid-based formulations had been independent of digestion even though data from in vitro lipolysis with conventional sampling indicated the opposite. Overall, microdialysis is a promising and complementary sampling technique for the evaluation of lipid-based formulations by in vitro lipolysis.

Authors

Institutions

Publication Details

Journal
Molecular Pharmaceutics
Published
2025-10-03
DOI
https://doi.org/10.1021/acs.molpharmaceut.5c00640
Citations
2
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
1.58
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Looking behind the Solubilization Curtain: Microdialysis Provides Near-Real-Time Noncolloidal Drug Concentrations during In Vitro Lipolysis

Annette Bauer‐Brandl, Ann-Christin Jacobsen, Martin Brandl, Felix Paulus et al.
2 citations
Molecular Pharmaceutics
Drug Solubulity and Delivery Systems
1.58
article

Looking behind the Solubilization Curtain: Microdialysis Provides Near-Real-Time Noncolloidal Drug Concentrations during In Vitro Lipolysis

Annette Bauer‐Brandl, Ann-Christin Jacobsen, Martin Brandl, Felix Paulus, Mikkel Højmark Tønning
article en
2 citations

Abstract

Lipid-based formulations can enhance the oral absorption of poorly water-soluble drugs. Their performance is typically evaluated by in vitro lipolysis. For this, samples are usually prepared by centrifugation, and formulation performance is evaluated based on the concentration in the aqueous phase. However, several studies have questioned the predictiveness of the in vitro lipolysis method. A reason for the in vitro-in vivo mismatch may be that centrifugation cannot separate truly dissolved drug molecules from molecules associated with colloidal assemblies such as mixed micelles. The present study tested microdialysis as an alternative sampling technique for in vitro lipolysis by which truly dissolved drug molecules (i.e., the free fraction) can be separated from colloid-associated drug molecules. Thereby, a better mechanistic understanding of the formulation performance will possibly be achieved. Indomethacin and a medium-chain type IIIB lipid-based formulation were used as model drug and model formulation, respectively. Microdialysis sampling was found compatible with lipolysis medium with bile salts, phospholipids, and pancreatic enzymes. In a proof-of-concept study, microdialysis provided near-real-time concentrations of free indomethacin during the in vitro lipolysis process and revealed supersaturation of indomethacin. However, indomethacin supersaturation was also observed under nonlipolytic conditions. Based on microdialysis data, digestion would not influence the formulation performance. In contrast, conventional samples showed that lipolysis significantly decreased the solubilization capacity of the formulation. Other examples have been described in the literature where oral absorption from lipid-based formulations had been independent of digestion even though data from in vitro lipolysis with conventional sampling indicated the opposite. Overall, microdialysis is a promising and complementary sampling technique for the evaluation of lipid-based formulations by in vitro lipolysis.

Molecular PharmaceuticsVol. 22(11)
University of Southern Denmark (DK), Christian-Albrechts-Universität zu Kiel (DE)
Openalex Percentile: Top 15%
Drug Solubulity and Delivery Systems
1.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.